Adjuvant Trastuzumab Reduces Locoregional Recurrence in Women Who Receive Breast-Conservation Therapy for Lymph Node-Negative, Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

Steven Register(University of Miami), Jean L. Wright(University of North Carolina at Chapel Hill)
Breast Diseases A Year Book Quarterly
January 1, 2012
Cited by 18


Related Papers